Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NQO2 | P16083 | 6/20 | 0.56 |
| ▸ | MAPT | P10636 | 4/20 | 0.53 |
| ▸ | RAB9A | P51151 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | NPC1 | O15118 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | GAA | P10253 | 2/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7074871 | 0.83 | NQO2 (0.42) | NQO2MAPTRAB9AKMT2ANPC1 | |
| SCHEMBL5798945 | 0.83 | NQO2 (0.81) | NQO2MAPTRAB9AKMT2ANPC1 | |
| SCHEMBL28705258 | 0.83 | NQO2 (0.42) | NQO2MAPTRAB9AKMT2ANPC1 | |
| SCHEMBL183009 | 0.82 | NQO2 (0.57) | NQO2MAPTRAB9AKMT2ANPC1 | |
| Bromide SCHEMBL11421481 | 0.80 | NQO2 (0.55) | NQO2MAPTRAB9AKMT2ANPC1 | |
| SCHEMBL7567602 | 0.80 | ALDH1A1 (0.61) | MAPTALDH1A1KDM4EHPGDHSD17B10 | |
| SCHEMBL13181658 | 0.80 | NQO2 (0.46) | NQO2MAPTRAB9ANPC1ALDH1A1 | |
| SCHEMBL1010318 | 0.79 | MAPT (0.55) | NQO2MAPTRAB9AKMT2ANPC1 | |
| Phenazine SCHEMBL29098643 | 0.79 | MAPT (0.55) | NQO2MAPTRAB9AKMT2ANPC1 | |
| SCHEMBL29645243 | 0.79 | MAPT (0.55) | NQO2MAPTRAB9AKMT2ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8802975-B2 | Compounds for organic thin-film solar cells and organic thin-film solar cells | Wong, Ken-Tsung (TW) | 2014-08-12 | — | — | US | disclosed |
| US-8802975-B2 | Compounds for organic thin-film solar cells and organic thin-film solar cells | Wong, Ken-Tsung (TW) | 2014-08-12 | — | — | US | disclosed |
| US-20130027636-A1 | CLASS OF BRIDGED BIPHENYLENE POLYMERS | SUMITOMO CHEMICAL CO., LTD. (JP) | 2013-01-31 | — | — | US | disclosed |
| US-20130027636-A1 | CLASS OF BRIDGED BIPHENYLENE POLYMERS | SUMITOMO CHEMICAL CO., LTD. (JP) | 2013-01-31 | — | — | US | disclosed |
| WO-2013016187-A1 | COMPOUNDS FOR ORGANIC THIN-FILM SOLAR CELLS AND ORGANIC THIN-FILM SOLAR CELLS | WONG KEN-TSUNG | 2013-01-31 | — | — | WO | disclosed |
| US-20130019949-A1 | COMPOUNDS FOR ORGANIC THIN-FILM SOLAR CELLS AND ORGANIC THIN-FILM SOLAR CELLS | Lin, Hao-Wu | 2013-01-24 | — | — | US | disclosed |
| US-20130019949-A1 | COMPOUNDS FOR ORGANIC THIN-FILM SOLAR CELLS AND ORGANIC THIN-FILM SOLAR CELLS | Lin, Hao-Wu | 2013-01-24 | — | — | US | disclosed |
| US-20120264977-A1 | TRIARYLAMINE CONTAINING POLYMERS AND ELECTRONIC DEVICES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-10-18 | — | — | US | disclosed |
| US-20120264977-A1 | TRIARYLAMINE CONTAINING POLYMERS AND ELECTRONIC DEVICES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-10-18 | — | — | US | disclosed |
| US-8247800-B2 | Triarylamine containing polymers and electronic devices | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-08-21 | — | — | US | disclosed |
| US-20090066224-A1 | DICARBAZOLE AROMATIC AMINE POLYMERS AND ELECTRONIC DEVICES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-03-12 | — | — | US | disclosed |
| US-20090001324-A1 | Salicylate Substituted Conjugated Polymers and Devices | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-01-01 | — | — | US | disclosed |
| US-20090001324-A1 | Salicylate Substituted Conjugated Polymers and Devices | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-01-01 | — | — | US | disclosed |
| US-20080265755-A1 | Biscarbazol-9-Yl-Substituted Triarylamine-Containing Polymers and Electronic Devices | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2008-10-30 | — | — | US | disclosed |
| US-20080265755-A1 | Biscarbazol-9-Yl-Substituted Triarylamine-Containing Polymers and Electronic Devices | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2008-10-30 | — | — | US | disclosed |
| US-20080011353-A1 | Triarylamine Containing Polymers and Electronic Devices | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2008-01-17 | — | — | US | disclosed |
| US-20080011353-A1 | Triarylamine Containing Polymers and Electronic Devices | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2008-01-17 | — | — | US | disclosed |
| EP-1576032-B1 | TRICYCLIC ARYLAMINE MONOMER AND POLYMERS AND DEVICES THEREOF | DOW GLOBAL TECHNOLOGIES INC (US) | 2007-10-17 | — | — | EP | disclosed |
| US-20070102695-A1 | Crosslinkable substituted fluorene compounds and conjugated oligomers or polymers based thereon | DOW GLOBAL TECHNOLOGIES INC. | 2007-05-10 | — | — | US | disclosed |
| US-20070102695-A1 | Crosslinkable substituted fluorene compounds and conjugated oligomers or polymers based thereon | DOW GLOBAL TECHNOLOGIES INC. | 2007-05-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090066224-A1 | DICARBAZOLE AROMATIC AMINE POLYMERS AND ELECTRONIC DEVICES | NAT1, SAT1, RIF1 | NQO2 2310/4885MAPT 1378/4885RAB9A 2990/4885 |
| US-20120264977-A1 | TRIARYLAMINE CONTAINING POLYMERS AND ELECTRONIC DEVICES | NAT1, AHR, AR | NQO2 4105/4885MAPT 3376/4885RAB9A 2589/4885 |
| US-20070102695-A1 | Crosslinkable substituted fluorene compounds and conjugated oligomers or polymers based thereon | THEM6, PCNA, PARG | NQO2 2203/4885MAPT 107/4885RAB9A 1267/4885 |
| US-20090001324-A1 | Salicylate Substituted Conjugated Polymers and Devices | TLR9, TLR5, TLR1 | NQO2 4316/4885MAPT 342/4885RAB9A 4271/4885 |
| US-20130019949-A1 | COMPOUNDS FOR ORGANIC THIN-FILM SOLAR CELLS AND ORGANIC THIN-FILM SOLAR CELLS | CDH1, FTO, SUN2 | NQO2 2316/4885MAPT 1180/4885RAB9A 542/4885 |
| US-20080265755-A1 | Biscarbazol-9-Yl-Substituted Triarylamine-Containing Polymers and Electronic Devices | PYM1, KCNMB4, BRD9 | NQO2 3715/4885MAPT 2713/4885RAB9A 1613/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.